Efficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models-Reference-Cited by-同舟云学术

Efficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models

Published:2016-03 Issue:3 Volume:5 Page:140-146
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Allen RJ¹,Rieger TR¹,Musante CJ¹

Affiliation:

1. Cardiovascular and Metabolic Diseases Research Unit, Pfizer Inc.Cambridge Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12063

Reference21 articles.

1. Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development

2. Next-Generation Model-Based Drug Discovery and Development: Quantitative and Systems Pharmacology

3. Sorger P.K.et al. Quantitative and systems pharmacology in the post‐genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. A NIH White Paper by the QSP Workshop Group‐October 2011 (2011).

4. A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling

5. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building virtual patients using simulation-based inference;Frontiers in Systems Biology;2024-09-12

2. Assessing the Role of Patient Generation Techniques in Virtual Clinical Trial Outcomes;Bulletin of Mathematical Biology;2024-08-13

3. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;Molecular Cancer;2024-08-02

4. Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients;2024-08-02

5. From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling;npj Digital Medicine;2024-07-16